Inhibition of AChE is considered as a promising strategy for the treatment of some diseases caused by the too low level of ACh, such as glaucoma, myasthenia gravis, gastric motility and Alzheimer’s disease (1-4). The gene discussed is ACHE; the disease is myasthenia gravis.